Early-learning technology company TALi Digital (ASX:TD1) is causing a stir on the market, releasing much-awaited initial results from a study using its TALi Detect platform.
TALi Detect is a mobile app to screen children for deficits of attention and the recent study is the company’s first ever large-scale activity, with approximately 1,000 students taking part.
The vast majority of participants were children aged 5 to 7 and screened in a normal classroom environment as part of an agreement with the Victorian public education system.
According to the study, approximately 13% of children were identified as having attention issues compared to other classmates and peers.
TALi Detect’s figures are broadly in-line with academic estimates, with the number of children with attention issues, including those with the more severe Attention-deficit/Hyperactivity Disorder (ADHD), believed to be between 3 to 15 percent.
Overall, the study is expected to screen at least 5,000 children across the nation, potentially identifying a significantly larger overall number of children with attention issues.
Commenting on the results, TALi Digital managing director Glenn Smith said:
These initial results from the first 1000 school-aged children to have used TALi Detect are very pleasing as they show that the program can be deployed in real-life school conditions with very high customer satisfaction ratings and may provide the foundation for further interventions such as our TALi Train program.”
The scale of the number of children with attention issues will have the company’s investors eyeing a hefty pipeline of potential sales for its TALi Train solution.
TALi Train is the second part of the company’s one-two punch. It is another mobile app developed by the company which is clinically proven to deliver therapy to improve attention rates in children aged 3 to 8.
The mobile app is cleared by the regulatory authorities in Australia, USA and EU and is even included in national healthcare programs, for example through CPT Codes for reimbursement in the US and Australia’s National Disability Insurance Scheme.